Karl Frederic and Team Complete Sale of Pharma Campus Parcel Slated for Redevelopment in East Hanover, NJ

Monday, December 27, 2021

Karl Frederic and a team that included Andrew Craig with respect to environmental matters and Chuck Liebling and Sandy Galacio with respect to land use issues recently represented a prominent pharmaceutical company in the sale of nearly a third of its U.S. headquarters campus in East Hanover, New Jersey, to a partnership comprised of prominent local developers Russo Development and Onyx Equities. The 62-acre parcel of vacant office buildings is to be transformed into two modern distribution center buildings. News of the sale was reported in Real Estate NJ, ROI-NJ and The Patch.